/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
and analysis for the period ended June 30, 2018 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the reviewed financial statements for quarter 2/2018 of Wiik
1 Translation CEN 031-2018 August 14, 2018 Subject : Management Discussion and Analysis for business operation of Quarter 2-2018 To : The Manager and President The Stock Exchange of Thailand Business
-Translation- No. ECF2 041/2561 12 November 2018 Subject: Management Discussion and Analysis of the 3rd quarter ended September 30, 2018 To President The Stock Exchange of Thailand East Coast
, 2018 1. Analysis of operation results for the third quar ter of 2018 in compar ison with those for the same quar ter of 2017 (from the consolidated financial statements) Items Third quarter of 2018 Third
No. 256111002 14 November 2018 Subject: Management Discussion and Analysis for the third quarter ended 30 September 2018 To: President The Stock Exchange of Thailand M Vision Public Company Limited
เปลี่ยนแปลง (sensitivity analysis) ที่ผานการตรวจสอบจากผูสอบบัญชีหรือที่ปรึกษาทางการเงิน ที่ไดรับความเห็นชอบจากสํานักงาน หรือบุคคลอื่นใดตามที่สํานักงานใหความเห็นชอบ ทั้งนี้ ประมาณ การรายไดคาเชาที่แสดงตอง
Discussion and Analysis, Quarter 1 Ending 31 March 2020 (4) The Impact of the COVID-19 situation To: President of the Stock Exchange of Thailand Reference: (1) Document no. Tor. For. 4/2020 dated April 10
Translation DIMET AC 2008/001 August 31, 2020 Subject Management Discussion and Analysis for business operation year 2019 (July 1, 2019 - June 30, 2020) To The Manager and President The Stock